These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3769710)
41. Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue. Kyriatsoulis A; Manns M; Gerken G; Lohse AW; Ballhausen W; Reske K; Meyer zum Büschenfelde KH Clin Exp Immunol; 1987 Oct; 70(1):53-60. PubMed ID: 3690894 [TBL] [Abstract][Full Text] [Related]
42. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Clifford BD; Donahue D; Smith L; Cable E; Luttig B; Manns M; Bonkovsky HL Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Todros L; Saracco G; Durazzo M; Abate ML; Touscoz G; Scaglione L; Verme G; Rizzetto M Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650 [TBL] [Abstract][Full Text] [Related]
44. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Abuaf N; Johanet C; Chretien P; Martini E; Soulier E; Laperche S; Homberg JC Hepatology; 1992 Oct; 16(4):892-8. PubMed ID: 1398495 [TBL] [Abstract][Full Text] [Related]
45. Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. Sacher M; Blümel P; Thaler H; Manns M J Hepatol; 1990 May; 10(3):364-9. PubMed ID: 2195110 [TBL] [Abstract][Full Text] [Related]
49. Does the immune response play a role in the pathogenesis of chronic liver disease? Mondelli MU; Manns M; Ferrari C Arch Pathol Lab Med; 1988 May; 112(5):489-97. PubMed ID: 3282484 [TBL] [Abstract][Full Text] [Related]
50. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483 [TBL] [Abstract][Full Text] [Related]
51. [Significance of immunologic reactions for the diagnosis and pathogenesis of chronic hepatitis]. Schumacher K Klin Wochenschr; 1969 Sep; 47(18):949-59. PubMed ID: 4913990 [No Abstract] [Full Text] [Related]
52. Occurrence of autoimmune antibodies to liver microsomal proteins in association with fulminant hepatitis in the LEC strain of rats. Nagayama S; Kitamura R; Yokoi T; Kawaguchi Y; Kasai N; Takeichi N; Kobayashi H; Kamataki T Biochem Biophys Res Commun; 1991 Sep; 179(2):1134-40. PubMed ID: 1898395 [TBL] [Abstract][Full Text] [Related]
53. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine. Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985 [TBL] [Abstract][Full Text] [Related]
54. [Clinical value of anti-liver/kidney microsomal-1 antibody in patients with liver disease]. Han Y; Yan HP; Liao HY; Sun LM; Huang YL; Huang CY; Zhang HP; Zhang XD; Bian XQ; Ren MX; Du XF; Liu YM Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):852-857. PubMed ID: 29325280 [No Abstract] [Full Text] [Related]
57. [Quantitative alterations of the immunoglobuline classes and the presence of autoantibodies in liver diseases (author's transl)]. Ossena A; Gola F; Raho L; Taroni G Quad Sclavo Diagn; 1978 Sep; 15(3):316. PubMed ID: 379904 [TBL] [Abstract][Full Text] [Related]
58. [Immunopathogenesis of chronic inflammatory liver diseases]. Meyer zum Büschenfelde Ergeb Inn Med Kinderheilkd; 1972; 32():31-81. PubMed ID: 4556562 [No Abstract] [Full Text] [Related]